Thanks to one-time proceeds from a patent sale, PACS firm Sectra experienced sharply higher sales and operating profit for the first quarter of its 2014/2015 fiscal year.
For the quarter (end-31 July), net sales rose 21.2% to 212 million Swedish krona (23.1 million euros). Operating profit rose by 191.4% to 40.5 million Swedish krona (4.4 million euros), which corresponds to an operating margin of 19%. Sectra attributes the growth to the sale and licensing of patents.
Also, Sectra has increased order bookings by 56.7%; they rose to 388 million Swedish krona (42.3 million euros). This is due to several long-term customer contracts with major healthcare suppliers in the U.S., U.K., and Scandinavia, Sectra said.